CA2084677C - Polypeptides apo ai, anticorps et immuno-essais - Google Patents

Polypeptides apo ai, anticorps et immuno-essais Download PDF

Info

Publication number
CA2084677C
CA2084677C CA002084677A CA2084677A CA2084677C CA 2084677 C CA2084677 C CA 2084677C CA 002084677 A CA002084677 A CA 002084677A CA 2084677 A CA2084677 A CA 2084677A CA 2084677 C CA2084677 C CA 2084677C
Authority
CA
Canada
Prior art keywords
apo
polypeptide
amino acid
acid residue
sequence represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002084677A
Other languages
English (en)
Other versions
CA2084677A1 (fr
Inventor
Linda K. Curtiss
Carole L. Banka
David J. Bonnet
Richard S. Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Publication of CA2084677A1 publication Critical patent/CA2084677A1/fr
Application granted granted Critical
Publication of CA2084677C publication Critical patent/CA2084677C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002084677A 1990-06-07 1991-06-07 Polypeptides apo ai, anticorps et immuno-essais Expired - Fee Related CA2084677C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US534,761 1990-04-07
US53476190A 1990-06-07 1990-06-07
PCT/US1991/004038 WO1991018619A1 (fr) 1990-06-07 1991-06-07 Polypeptides d'apo ai, anticorps anti-apo ai et analyses immunologiques les utilisant

Publications (2)

Publication Number Publication Date
CA2084677A1 CA2084677A1 (fr) 1991-12-08
CA2084677C true CA2084677C (fr) 2003-11-04

Family

ID=24131429

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002084677A Expired - Fee Related CA2084677C (fr) 1990-06-07 1991-06-07 Polypeptides apo ai, anticorps et immuno-essais

Country Status (6)

Country Link
EP (1) EP0500826A4 (fr)
JP (1) JPH06508344A (fr)
CA (1) CA2084677C (fr)
IE (1) IE911922A1 (fr)
PT (1) PT97914B (fr)
WO (1) WO1991018619A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7125678B2 (en) * 2001-11-23 2006-10-24 Nanogen, Inc. Protein biopolymer markers predictive of type II diabetes
LT2631248T (lt) 2007-06-15 2018-04-25 Medigene Ag Navikų gydymas, naudojant specifinį anti-l1 antikūną
NO335243B1 (no) 2008-01-08 2014-10-27 Isola As Knasteplate, samt anvendelse og fremgangsmåte for legging av et gulvbelegg ved bruk av en slik knasteplate.
WO2018181935A1 (fr) * 2017-03-30 2018-10-04 シスメックス株式会社 Anticorps anti-apoa1
JP2023178881A (ja) * 2022-06-06 2023-12-18 国立大学法人千葉大学 ナノディスクに対する高親和性抗ｍｓｐモノクローナル抗体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055396A (en) * 1987-11-03 1991-10-08 Scripps Clinic And Research Foundation Diagnostic methods and systems for quantifying apo ai
WO1989009403A1 (fr) * 1988-03-29 1989-10-05 Scripps Clinic And Research Foundation Procedes et systemes de diagnostic quantifiant l'apo ai

Also Published As

Publication number Publication date
PT97914B (pt) 1998-11-30
IE911922A1 (en) 1991-12-18
EP0500826A1 (fr) 1992-09-02
WO1991018619A1 (fr) 1991-12-12
CA2084677A1 (fr) 1991-12-08
EP0500826A4 (en) 1993-06-30
PT97914A (pt) 1992-03-31
JPH06508344A (ja) 1994-09-22

Similar Documents

Publication Publication Date Title
US5814467A (en) APO AI polypeptides, diagnostic methods and systems for quantifying APO AI, and therapeutic methods
US5168045A (en) Diagnostic systems and methods using polypeptide analogs of apolipoprotein e
US5473039A (en) Polypeptide analogs of apolipoprotein E, diagnostic systems and methods using the analogs
US5831032A (en) Interleukin-8 anti-peptide antibodies
CA1307479C (fr) Methodes diagnostiques et systemes pour quantifier un apo ai
EP0972781B1 (fr) Polypeptides de la protéine S et leurs utilisations
CA2084677C (fr) Polypeptides apo ai, anticorps et immuno-essais
EP0592600B1 (fr) Polypeptides de proteines s et leurs utilisations
IE83756B1 (en) Apo AI polypeptides, antibodies, and immunoassays
US7122324B2 (en) Vitro methods for determining in vivo thrombotic events
WO1989009403A1 (fr) Procedes et systemes de diagnostic quantifiant l'apo ai
AU621575B2 (en) Diagnostic methods and systems for quantifying apo ai
CA2023521A1 (fr) Analogues polypeptidiques d'apoliproproteine e, systemes de diagnostic et methodes dans lesquelles ces analogues sont utilises
NO894709L (no) Diagnosefremgangsmaater og -systemer for kvantifisering avapo ai.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed